Retatrutide 40mg weightloss

WEIGHTLOSS AT IT BEST

Retatrutide is an experimental, once-weekly injectable metabolic medication being developed by Eli Lilly. It is widely anticipated as the next-generation breakthrough for chronic weight management and type 2 diabetes mellitus (T2DM). Referred to informally as the "Triple G" or "Godzilla" jab, it stands out because it is a triple hormone receptor agonist. It simultaneously activates three distinct pathways in the body to control appetite, burn fat, and regulate blood sugar.

How Retatrutide Works

Unlike older medications that target one or two metabolic pathways, retatrutide mimics three separate gut hormones:

• GLP-1 (Glucagon-like peptide-1): Suppresses appetite and slows down stomach emptying so you feel full for longer.
• GIP (Glucose-dependent insulinotropic polypeptide): Enhances insulin release and lowers food intake while potentially buffering gastrointestinal issues.
• Glucagon (GCG): Boosts energy expenditure and speeds up how quickly the body breaks down stored fat into usable energy.